136 related articles for article (PubMed ID: 38501049)
1. Targeting bone marrow mechanosensation in myelofibrosis.
Vinchi F
Hemasphere; 2024 Mar; 8(3):e46. PubMed ID: 38501049
[No Abstract] [Full Text] [Related]
2. Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies.
Zahr AA; Salama ME; Carreau N; Tremblay D; Verstovsek S; Mesa R; Hoffman R; Mascarenhas J
Haematologica; 2016 Jun; 101(6):660-71. PubMed ID: 27252511
[TBL] [Abstract][Full Text] [Related]
3. Clinical Morphological Studies of Myelofibrosis with Different Types of Bone Marrow Involvement in Patients with Chronic Lymphocytic Leukemia.
Dolgikh TY; Sholenberg EV; Kachesov IV; Domnikova NP; Klinnikova MG
Bull Exp Biol Med; 2016 Jul; 161(3):408-11. PubMed ID: 27496034
[TBL] [Abstract][Full Text] [Related]
4. CD8
Yao Y; Li L; Yang SH; Gao CY; Liao LH; Xie YQ; Yin XY; Yang YQ; Fei YY; Lian ZX
J Autoimmun; 2018 May; 89():101-111. PubMed ID: 29307587
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow hypervascularity in patients with myelofibrosis identified by infra-red thermography.
Baglin TP; Crocker J; Timmins A; Chandler S; Boughton BJ
Clin Lab Haematol; 1991; 13(4):341-8. PubMed ID: 1773587
[TBL] [Abstract][Full Text] [Related]
6. CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.
Tripodo C; Di Bernardo A; Ternullo MP; Guarnotta C; Porcasi R; Ingrao S; Gianelli U; Boveri E; Iannitto E; Franco G; Florena AM
Haematologica; 2009 Jan; 94(1):127-30. PubMed ID: 19029148
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up.
Ghanima W; Geyer JT; Lee CS; Boiocchi L; Imahiyerobo AA; Orazi A; Bussel JB
Haematologica; 2014 May; 99(5):937-44. PubMed ID: 24463212
[TBL] [Abstract][Full Text] [Related]
8. [Pathological Characteristics of Bone Marrow in Multiple Myeloma Patients with Secondary Myelofibrosis and Their Relationship with Prognosis].
Zhao J; Ma L; Guan JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1080-1085. PubMed ID: 28823272
[TBL] [Abstract][Full Text] [Related]
9. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis.
Hasselbalch H; Lisse I
Eur J Haematol; 1991 May; 46(5):285-9. PubMed ID: 2044723
[TBL] [Abstract][Full Text] [Related]
10. [Pathological Characteristics of Bone Marrow in Non-Hodgkin's Lymphoma Patients with Secondary Myelofibrosis and Their Relationship with Prognosis].
Liu YL; Wang WJ; Wang XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):674-8. PubMed ID: 26117015
[TBL] [Abstract][Full Text] [Related]
11. A review of myelofibrosis in dogs.
Reagan WJ
Toxicol Pathol; 1993; 21(2):164-9. PubMed ID: 8210938
[TBL] [Abstract][Full Text] [Related]
12. Assessment of bone marrow and splenic erythropoiesis in myelofibrosis.
Ferrant A; Rodhain J; Cauwe F; Cogneau M; Beckers C; Michaux JL; Verwilghen R; Sokal G
Scand J Haematol; 1982 Nov; 29(5):373-80. PubMed ID: 7156888
[TBL] [Abstract][Full Text] [Related]
13. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].
Bedekovics J; Méhes G
Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557
[TBL] [Abstract][Full Text] [Related]
14. Reversible bone marrow aplasia induced by pegylated interferon-α-2a therapy in a patient with primary myelofibrosis.
Mainali NR; Bhatt VR; Kedia S; Krishnamurthy J; Wake LM; Akhtari M
J Oncol Pharm Pract; 2014 Oct; 20(5):386-92. PubMed ID: 24067929
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia.
Wang JC; Lang HD; Lichter S; Weinstein M; Benn P
Br J Haematol; 1992 Feb; 80(2):184-8. PubMed ID: 1550774
[TBL] [Abstract][Full Text] [Related]
16. The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis.
Kirabo A; Park SO; Wamsley HL; Gali M; Baskin R; Reinhard MK; Zhao ZJ; Bisht KS; Keserű GM; Cogle CR; Sayeski PP
Am J Pathol; 2012 Sep; 181(3):858-65. PubMed ID: 22796437
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
18. A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis.
Hasselbalch H; Jans H; Nielsen PL
Am J Hematol; 1987 Jun; 25(2):225-9. PubMed ID: 3605072
[TBL] [Abstract][Full Text] [Related]
19. Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis.
Kröger N; Kvasnicka M; Thiele J
Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S25. PubMed ID: 23259545
[TBL] [Abstract][Full Text] [Related]
20. Properties of myelofibrosis-derived fibroblasts.
Castro-Malaspina H; Jhanwar SC
Prog Clin Biol Res; 1984; 154():307-22. PubMed ID: 6382300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
